Randomized Double Blind Controlled Trial on Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Sulodexide (Primary)
- Indications Thrombosis; Tinnitus
- Focus Therapeutic Use
- Acronyms SECIST
- 22 Jan 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
- 22 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 23 Oct 2016 Planned End Date changed from 1 Aug 2016 to 1 Mar 2017.